These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8947306)

  • 21. Reduction of ethanol intake by chronic treatment with Hypericum perforatum, alone or combined with naltrexone in rats.
    Perfumi M; Mattioli L; Cucculelli M; Massi M
    J Psychopharmacol; 2005 Sep; 19(5):448-54. PubMed ID: 16166181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls.
    Mitchell JM; Tavares VC; Fields HL; D'Esposito M; Boettiger CA
    Neuropsychopharmacology; 2007 Feb; 32(2):439-49. PubMed ID: 17047667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of saccharin intake and expression of fructose-conditioned flavor preferences following opioid receptor antagonism in the medial prefrontal cortex, amygdala or lateral hypothalamus in rats.
    Malkusz DC; Bernal SY; Banakos T; Malkusz G; Mohamed A; Vongwattanakit T; Bodnar RJ
    Neurosci Lett; 2014 Apr; 564():94-8. PubMed ID: 24560952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.
    Froehlich JC; Hausauer BJ; Rasmussen DD
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1763-70. PubMed ID: 23875623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of naltrexone administered repeatedly across 30 or 60 days on ethanol consumption using a limited access procedure in the rat.
    Stromberg MF; Volpicelli JR; O'Brien CP
    Alcohol Clin Exp Res; 1998 Dec; 22(9):2186-91. PubMed ID: 9884167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.
    Spagnolo PA; Ramchandani VA; Schwandt ML; Zhang L; Blaine SK; Usala JM; Diamond KA; Phillips MJ; George DT; Momenan R; Heilig M
    Alcohol Clin Exp Res; 2014 Dec; 38(12):3024-32. PubMed ID: 25581657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electroacupuncture reduces voluntary alcohol intake in alcohol-preferring rats via an opiate-sensitive mechanism.
    Overstreet DH; Cui CL; Ma YY; Guo CY; Han JS; Lukas SE; Lee DY
    Neurochem Res; 2008 Oct; 33(10):2166-70. PubMed ID: 18633703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone.
    Bach P; Weil G; Pompili E; Hoffmann S; Hermann D; Vollstädt-Klein S; Mann K; Perez-Ramirez U; Moratal D; Canals S; Dursun SM; Greenshaw AJ; Kirsch P; Kiefer F; Sommer WH
    Addict Biol; 2020 Jan; 25(1):e12717. PubMed ID: 30748046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prazosin + Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in P Rats with a Protracted History of Extensive Voluntary Alcohol Drinking, Dependence, and Multiple Withdrawals.
    Rasmussen DD; Kincaid CL; Froehlich JC
    Alcohol Clin Exp Res; 2015 Sep; 39(9):1832-41. PubMed ID: 26260061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the hallucinogenic beverage ayahuasca on voluntary ethanol intake by rats and on cFos expression in brain areas relevant to drug addiction.
    Nolli LM; de Oliveira DGR; Alves SS; von Zuben MV; Pic-Taylor A; Mortari MR; Caldas ED
    Alcohol; 2020 May; 84():67-75. PubMed ID: 31698029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.
    O'Malley SS; Garbutt JC; Gastfriend DR; Dong Q; Kranzler HR
    J Clin Psychopharmacol; 2007 Oct; 27(5):507-12. PubMed ID: 17873686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages.
    Reid LD; Delconte JD; Amendola CA; Nichols ML; Krupsky GW; Dharia NS; Hubbell CL
    Behav Pharmacol; 1994 Aug; 5(4 And 5):485-493. PubMed ID: 11224300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of extended-release naltrexone on holiday drinking in alcohol-dependent patients.
    Lapham S; Forman R; Alexander M; Illeperuma A; Bohn MJ
    J Subst Abuse Treat; 2009 Jan; 36(1):1-6. PubMed ID: 18775624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Naltrexone increases the latency to drink alcohol in social drinkers.
    Davidson D; Swift R; Fitz E
    Alcohol Clin Exp Res; 1996 Jun; 20(4):732-9. PubMed ID: 8800392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in the incentive value of food after naltrexone treatment depend on a differential preference for a palatable food in male rats.
    Alvarado-Bañuelos M; Barrios De Tomasi E; Juárez J
    Nutr Neurosci; 2017 Sep; 20(7):416-423. PubMed ID: 28277185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study.
    Lukas SE; Lowen SB; Lindsey KP; Conn N; Tartarini W; Rodolico J; Mallya G; Palmer C; Penetar DM
    Neuroimage; 2013 Sep; 78():176-85. PubMed ID: 23571420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Naturalistic Evaluation of Extended-Release Naltrexone in Clinical Practice in Missouri.
    Crits-Christoph P; Markell HM; Gibbons MB; Gallop R; Lundy C; Stringer M; Gastfriend DR
    J Subst Abuse Treat; 2016 Nov; 70():50-57. PubMed ID: 27692188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Opioidergic, serotonergic, and dopaminergic manipulations and rats' intake of a sweetened alcoholic beverage.
    Hubbell CL; Marglin SH; Spitalnic SJ; Abelson ML; Wild KD; Reid LD
    Alcohol; 1991; 8(5):355-67. PubMed ID: 1797032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of naltrexone on alcohol self-administration in heavy drinkers.
    Davidson D; Palfai T; Bird C; Swift R
    Alcohol Clin Exp Res; 1999 Feb; 23(2):195-203. PubMed ID: 10069545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continuous delivery of naltrexone and nalmefene leads to tolerance in reducing alcohol drinking and to supersensitivity of brain opioid receptors.
    Korpi ER; Linden AM; Hytönen HR; Paasikoski N; Vashchinkina E; Dudek M; Herr DR; Hyytiä P
    Addict Biol; 2017 Jul; 22(4):1022-1035. PubMed ID: 26990998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.